Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in AXSOME THERAPEUTICS INC
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 87,249 shares of AXSM (AXSOME THERAPEUTICS INC), worth $15.9M as of 2025-Q4. The position was increased (++0.6% shares). AXSM represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.
Current Value
$15.9M
Current Shares
87,249
Total Value Change
+$11.4M
Total Shares Change
+31,056
Increased |
| 87,249 |
+0.6% |
| $15.9M |
| 0.0% |
| $148.79 |
28 |
| 2025-Q3 | Decreased | 86,691 | -35.4% | $10.5M | 0.0% | $117.62 | 0 |
| 2025-Q2 | Increased | 134,101 | +79.1% | $14M | 0.0% | $103.36 | 43 |
| 2025-Q1 | Increased | 74,892 | +29.9% | $8.7M | 0.0% | $118.53 | 35 |
| 2024-Q4 | Increased | 57,642 | +20.8% | $4.9M | 0.0% | $84.78 | 32 |
| 2024-Q3 | Decreased | 47,714 | -15.1% | $4.3M | 0.0% | $89.64 | 0 |
| 2024-Q2 | Increased | 56,193 | +94.8% | $4.5M | 0.0% | $80.50 | 43 |